Stocks
ABIOMED (ABMD) FCF conversion US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| FCF conversion, % | 83.1% | 90.2% | 105.2% | 89.6% | 49.9% | 46.2% | |||
| Changes by years, y/y, % | +15pp | +7pp | +15pp | -16pp | -40pp | -6.1% | |||
ABIOMED. FCF conversion, %
ABIOMED. FCF conversion, changes, pp
ABIOMED (ABMD) FCF conversion US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| FCF conversion, % | 80.3% | 117.3% | 69.8% | 76.4% | 3.45% | 46.2% | ||
| Changes by years, y/y, % | -24pp | +23pp | -18pp | +51pp | -77pp | |||
| Changes by quarters, q/q, % | +55pp | +37pp | -48pp | +7pp | -73pp | |||
